Article

MLI names new top executive and changes its name

Lisbon, Portugal - MLI (formerly Massie Laboratories), of Pleasanton, CA, United States, and manufacturers of diagnostic and data capture system for the eye-care market, has named Keith Mullowney as the company’s new president, chief executive officer, and board chairman. The company also changed its name to Clarity Medical Systems.

Lisbon, Portugal - MLI (formerly Massie Laboratories), of Pleasanton, CA, United States, and manufacturers of diagnostic and data capture system for the eye-care market, has named Keith Mullowney as the company’s new president, chief executive officer, and board chairman. The company also changed its name to Clarity Medical Systems.

Mullowney brings more than 20 years of management experience in the medical technology industry to the company. Recently, he served as chairman of Thermage, a medical device company specializing in the aesthetic market. Mullowney co-founded and led this company as president and chief executive officer for 7 years.  Mullowney also held top management positions at Aprex, a device and health-care information technology firm, and at Synvasive, a specialty orthopedic device manufacturer.

The name change to Clarity Medical Systems comes as the company reviews its mission.

“Clarity speaks to the ability to see and understand acuity and insight,” Mullowney said. “This is an ideal name for the future of the company because it represents both what our technology is designed to do, as well as our vision for transforming the delivery of eye health care.”

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
© 2025 MJH Life Sciences

All rights reserved.